38.60
+0.89%
Close of 9 Nov 2026, in CNY
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Nanjing Vishee Medical Technology Co
Its shares trade on Shanghai under the ticker 688580.SS. It has been listed since 21 July 2020. In the fiscal year to 31 December 2025, it reported revenue of CN¥462.7m and net income of CN¥136.6m. At that date it held total assets of CN¥1.91bn and shareholders' equity of CN¥1.69bn.
Nanjing Vishee Medical Technology Co., Ltd. manufactures electrical and magnetic stimulators for pelvic floor, postnatal, neurological and mental rehabilitation. The company is headquartered in Nanjing, Jiangsu. The company went IPO on 2020-07-21. The Company’s products are mainly electrical stimulation, magnetic stimulation, electrophysiological equipment, consumables and accessories and other rehabilitation medical equipment and products, such as pelvic floor muscle recovery equipment, transcranial magnetic stimulator, neonatal electroencephalography measuring instrument, rectal electrode, micro current stimulator and others. The firm mainly conducts its businesses within the domestic market.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Health Care Equipment & Supplies
- Listed since
- 21 Jul 2020
- Employees
- 686
- Website
- vishee.com ↗
Leadership
Pay as last reported
- Mr. Zhiyu WangChairman of the Board, General Manager, since 2021CN¥1.7m
- Ms. Lili ChenChief Financial Officer, Deputy General Manager, Director, since 2021CN¥643,900
- Mr. Hui ZhangDeputy General Manager, Director, since 2018CN¥667,700
- Mr. Chuan HanDeputy General Manager
- Mr. Kai QiuDeputy General ManagerCN¥595,200
- Ms. Yiqun ZhongDeputy General ManagerCN¥689,900
- Ms. Yihong TongSecretary of the Board
- Mr. Jinguo XuDirector, since 2021CN¥673,200
- Mr. Weihua CaiIndependent DirectorCN¥60,000
- Mr. Jialu WuIndependent Director
- Mr. Junfang XiaoIndependent DirectorCN¥7,500
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- The company manufactures specialized medical devices including electrical and magnetic stimulators for pelvic floor and neurological rehabilitation.
- It has a clear focus on rehabilitation medical equipment with products like transcranial magnetic stimulators and pelvic floor muscle recovery equipment.
- The company has a domestic market focus with a headquarters in Nanjing, Jiangsu.
Weaknesses
- The company's business is limited to the domestic market, which may restrict growth opportunities.
- The company has only 686 employees, which may limit its operational capacity.
- The company's products are specialized, potentially limiting market reach.
Opportunities
- Expanding into international markets could increase the company's customer base.
- Growing demand for rehabilitation medical equipment may provide new market opportunities.
- The company could leverage its IPO in 2020 to secure additional funding for expansion.
Threats
- Competition from other medical device manufacturers could impact market share.
- Regulatory changes in the healthcare sector may affect product approvals.
- Economic downturns could reduce demand for non-essential medical equipment.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.